Skip to main content

Official Journal of the Italian Society of Orthopaedics and Traumatology

Table 2 Generalities and patient demographics of the included studies

From: Selective versus non-selective NSAIDs as prophylaxis for heterotopic ossification following hip arthroplasty: a meta-analysis

Author, year, ref.

Follow-up (months)

Type of treatment

Type of protocol

Samples (n)

Mean age (years)

Female gender (%)

Barthel et al. 2002 [17]

12

Meloxicam

7.5 mg daily / 14 days

24

65

42%

Meloxicam

15 mg daily / 14 days

115

63

65%

Indomethacin

100 mg daily / 14 days

111

63

64%

Grohs et al. 2007 [7]

12

Rofecoxib

25 mg daily / 7 days

50

60

66%

Indomethacin

100 mg per daily / 7 days

50

60

60%

Legenstein et al. 2003 [34]

6

Indomethacin

150 mg daily / 12 days

58

68

59%

Meloxicam

7.5 mg daily / 12 days

58

65

74%

Romano et al. 1992 [35]

24

Indomethacin

100 mg per daily / 20 days

229

62

72%

Celecoxib

400 mg daily / 20 days

147

59

74%

Saudan et al. 2007 [25]

3

Celecoxib

400 mg daily / 10 days

117

69

53%

Ibuprofen

1200 mg daily / 10 days

123

70

54%

Van der Heide et al. 2004 [9]

6

Indomethacin

150 mg daily / 7 days

89

67

68%

Meloxicam

15 mg daily / 7 days

92

67

68%

Van der Heide et al. 2007 [36]

12

Indomethacin

150 mg daily / 7 days

89

 

62%

Rofecoxib

50 mg daily / 7 days

85

 

62%

Winkler et al. 2016 [4]

6

Diclofenac

150 mg daily / 9 days

44

61

45%

Etoricoxib

90 mg daily / 9 days

45

60

46%